Abstract
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
J E Leysen, W Gommeren, L Heylen, W H Luyten, I Van de Weyer, P Vanhoenacker, G Haegeman, A Schotte, P Van Gompel, R Wouters and A S Lesage
Molecular Pharmacology December 1996, 50 (6) 1567-1580;
J E Leysen
W Gommeren
L Heylen
W H Luyten
I Van de Weyer
P Vanhoenacker
G Haegeman
A Schotte
P Van Gompel
R Wouters
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Abstract
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
J E Leysen, W Gommeren, L Heylen, W H Luyten, I Van de Weyer, P Vanhoenacker, G Haegeman, A Schotte, P Van Gompel, R Wouters and A S Lesage
Molecular Pharmacology December 1, 1996, 50 (6) 1567-1580;
Abstract
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
J E Leysen, W Gommeren, L Heylen, W H Luyten, I Van de Weyer, P Vanhoenacker, G Haegeman, A Schotte, P Van Gompel, R Wouters and A S Lesage
Molecular Pharmacology December 1, 1996, 50 (6) 1567-1580;
Jump to section
Related Articles
Cited By...
Similar Articles
Advertisement